Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Methods of Medium Optimization01:28

Methods of Medium Optimization

Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peptide Marriages: Modular Assembly of Multi-Agonist Therapeutics.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

Discovery of molecular glues that bind FKBP12 and structurally distinct targets using DNA-encoded libraries.

Nature communications·2026
Same author

Author Correction: Diversity-oriented synthesis yields novel multistage antimalarial inhibitors.

Nature·2025
Same author

Publisher Correction: Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs.

Nature chemical biology·2025
Same author

Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs.

Nature chemical biology·2025
Same author

Highly specific intracellular ubiquitination of a small molecule.

Nature chemical biology·2025

Related Experiment Video

Updated: Jul 9, 2026

A Guided Materials Screening Approach for Developing Quantitative Sol-gel Derived Protein Microarrays
10:44

A Guided Materials Screening Approach for Developing Quantitative Sol-gel Derived Protein Microarrays

Published on: August 26, 2013

Towards the optimal screening collection: a synthesis strategy.

Thomas E Nielsen1, Stuart L Schreiber

  • 1Department of Chemistry and Chemical Biology, Harvard University, Howard Hughes Medical Institute, Cambridge, MA 02142, USA.

Angewandte Chemie (International Ed. in English)
|December 15, 2007
PubMed
Summary

Developing effective small molecules requires overcoming synthesis and screening challenges. A new diversity-oriented synthesis strategy shows promise for improving success rates across drug discovery, optimization, and manufacturing phases.

More Related Videos

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Related Experiment Videos

Last Updated: Jul 9, 2026

A Guided Materials Screening Approach for Developing Quantitative Sol-gel Derived Protein Microarrays
10:44

A Guided Materials Screening Approach for Developing Quantitative Sol-gel Derived Protein Microarrays

Published on: August 26, 2013

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Area of Science:

  • Synthetic chemistry
  • Medicinal chemistry
  • Drug discovery

Background:

  • Small-molecule drug and probe development involves distinct discovery, optimization, and manufacturing phases.
  • These stages are often handled by separate teams, leading to uncoordinated efforts and potential bottlenecks.
  • Current approaches lack integrated planning, hindering overall project efficiency.

Purpose of the Study:

  • To review emerging strategies in diversity-oriented synthesis for small molecules.
  • To explore approaches that enhance success probability across all development phases.
  • To address the challenge of creating screening collections with improved outcomes.

Main Methods:

  • Review of diversity-oriented synthesis strategies.
  • Analysis of small-molecule synthesis and screening methodologies.
  • Evaluation of potential for integrated planning in chemical development.

Main Results:

  • Progress is being made in developing new synthetic chemistry approaches.
  • Diversity-oriented synthesis offers a potential strategy to address multi-phase development challenges.
  • Emerging strategies aim to yield screening collections that improve success rates.

Conclusions:

  • Coordinated planning is crucial for efficient small-molecule development.
  • Diversity-oriented synthesis represents a promising avenue for future drug discovery and development.
  • Novel synthetic strategies are needed to overcome existing bottlenecks in the field.